EU Cancels Funding for UK Researchers in Ongoing Brexit Fallout

More than 100 grants previously approved for applicants in Britain have been scrapped amid a continuing dispute over the UK’s refusal to fully implement trade arrangements made when the country left the European Union.

Written byCatherine Offord
| 2 min read
Euro coin against a union jack flag
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

More than 100 UK researchers have lost out on EU funding amid an ongoing row over post-Brexit trade agreements. Of 150 grants approved by Europe’s principal research funder for applicants at British institutions last year, 115 have been terminated after a June 29 deadline set by the EU to urge UK action on those agreements passed, The Guardian reports. While some researchers will be able to take up their funding by moving to an EU institution, the majority have stayed in the UK and have thus been forced to forfeit the money.

Maria Leptin, president of the European Research Council (ERC), which oversees allocation of the funds, tells Science that she “profoundly” regrets the situation. “I sincerely hope that our political leaders will find a path to allow us to continue working in the future with the research community in the UK.”

The dispute stems from the UK’s refusal to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies